AL
ALDAR.PA Damartex
- Market cap
- EUR 26.2M
- P/E
- -
- P/B
- 0.66x
- ROE
- -90.8%
- Dividend yield
- -
- Fundamental score
- 1.0/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is ALDAR.PA undervalued?
Graham numberThe Graham number of Damartex cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Damartex fundamental analysis
3 of 11 checks passedROE 0/2
The stock's ROE indicates a negative return (-23.95%) on shareholders' equity, suggesting poor financial performance.
ROA 0/2
The stock's ROA (-8.9%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.
PBV 2/2
With a remarkably low PBV ratio (0.52x), the stock offers substantial upside potential at a bargain price.
DER 0/2
The stock is burdened with a heavy load of debt (180%), making it financially unstable and potentially risky for investors.
Revenue Growth 0/2
Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.
Net Profit Growth 0/2
Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.
Assets Growth 1/2
Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.
Graham Number 1/1
The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.
Dividend Growth 0/2
The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.
Dividend 0/2
The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.
Buffet Intrinsic Value 0/1
The company's stock presents a potential concern as it appears overvalued (-160) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Damartex stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Damartex
Damartex offers clothes and accessories for seniors primarily in France, Benelux, the United Kingdom, Germany, and Austria. It also offers fashion products under the Damart and Xandres brands; home and lifestyle products, including personal and household products under the 3Pagen, Coopers of Stortford, and Vitrine Magique brands; and healthcare products under the Santéol, Almadia and Msanté brands. In addition, the company provides services, such as management of patients wi…
Full company profileDamartex financial statements
Damartex annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 775K | 755K | 720K | 686M | 764M | 719M | 587M | 529M | 521M | 504M |
| Gross Profit | 507K | 489K | 466K | -11.3M | 20.5M | -8.94M | -19.8M | 337M | 1.82M | 336M |
| Operating Income | 22.3K | 16.9K | -3.26K | -25.5M | 21.9M | -1.84M | -10.6M | -30.2M | 2.10M | 500K |
| EBITDA | 34.6M | 30.0M | 10.9M | 4.44M | 55.3M | 35.3M | 10.0M | 1.69M | -400K | 500K |
| Net Income | 16.1K | 13.5K | -33.4K | -59.4M | 16.2M | -5.79M | -32.8M | -35.0M | -17.7M | -35.8M |
| EPS | 0.00 | 0.00 | 0.00 | -7.79 | 1.74 | -0.52 | -2.92 | -3.12 | -1.57 | -3.09 |
| Balance Sheet | ||||||||||
| Total Assets | 445K | 454K | 398K | 489M | 497M | 513M | 509M | 455M | 423M | 364M |
| Total Liabilities | 253K | 254K | 237K | 387M | 339M | 356M | 393M | 365M | 353M | 327M |
| Shareholders' Equity | 192K | 200K | 161K | 103M | 157M | 157M | 116M | 90.7M | 70.5M | 39.4M |
| Cash & Short-term Investments | 33.3K | 50.1K | 29.3K | 61.4M | 60.6M | 14.1M | 51.2M | 38.0M | 15.6M | 8.28M |
| Total Debt | 68.4M | 80.6M | 57.5M | 184M | 116M | 138M | 209M | 224M | 281M | 202M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 23.5K | 29.6K | 23.3K | 29.6M | 61.9M | -16.3M | 13.8M | 10.5M | 20.3M | 28.9M |
| Capital Expenditure | 12.6K | 11.2K | 9.26K | 12.6M | 9.18M | 16.4M | 14.8M | 9.23M | 5.95M | 11.4M |
| Free Cash Flow | 10.9K | 18.4K | 14.0K | 16.9M | 52.7M | -32.7M | -960K | 21.0M | 14.4M | 17.5M |
| Ratios | ||||||||||
| ROE | 8.4% | 6.7% | -20.8% | -57.8% | 10.3% | -3.7% | -28.3% | -38.6% | -25.1% | -90.8% |
| ROA | 3.6% | 3.0% | -8.4% | -12.1% | 3.3% | -1.1% | -6.4% | -7.7% | -4.2% | -9.8% |
| Net Profit Margin | 2.1% | 1.8% | -4.6% | -8.7% | 2.1% | -0.8% | -5.6% | -6.6% | -3.4% | -7.1% |
| Debt to Equity | 356.60x | 402.36x | 357.93x | 1.79x | 0.74x | 0.88x | 1.80x | 2.47x | 3.99x | 5.13x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Damartex dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Dec 2, 2022
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | EUR 31.0K | 0.00 | - |
| 2023 | EUR 1.20M | 0.11 | - |
| 2022 | EUR 4.59M | 0.41 | - |
| 2021 | EUR 45.0K | 0.00 | 0.3% |
| 2020 | EUR 15.1M | 1.98 | - |
| 2019 | EUR 3.43M | 0.45 | - |
| 2018 | EUR 4.54M | 0.60 | 33,687.0% |
| 2017 | EUR 4.53M | 0.59 | 28,043.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 159:146 on Oct 5, 2020.
Who owns Damartex
- Insiders 83.76%
- Institutions 0.43%
- Public & others 15.81%
- Shares outstanding 11.3M
- Free float 1.54M
Damartex company profile
- Company name
- Damartex
- Ticker
- ALDAR.PA
- ISIN
- FR0000185423
- Exchange
- Euronext Paris
- Sector
- Consumer Cyclical
- Industry
- Textiles, Apparel & Luxury Goods
- Employees
- 2,547
- Fiscal year end
- June
- Address
- 160 Boulevard de Fourmies, Roubaix, France, 59100
- Phone
- 33 3 20 99 44 00
- Website
- damartex.com
About Damartex
Damartex offers clothes and accessories for seniors primarily in France, Benelux, the United Kingdom, Germany, and Austria. It also offers fashion products under the Damart and Xandres brands; home and lifestyle products, including personal and household products under the 3Pagen, Coopers of Stortford, and Vitrine Magique brands; and healthcare products under the Santéol, Almadia and Msanté brands. In addition, the company provides services, such as management of patients with chronic or acute breathing disorders; and personalized support for the treatment of nocturnal sleep-related breathing disorders, as well as chronic pathologies requiring the implementation of oxygen therapy or even non-invasive ventilation at home. It sells its products through catalogues, stores, and e-commerce and marketplace sites, as well as wholesale sales to distributors and agents. The company was formerly known as Damart SA and changed its name to Damartex in 2002. Damartex was founded in 1953 and is headquartered in Roubaix, France.
Damartex management
2- Nicolas MarchandMember of the Supervisory Board & President of the Management Board
- Ms. Anne-Sylvie HubertGroup CFO, Member of the Supervisory Board & Member of Executive Board